The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.

A targeted computerized alert at the time of physician order entry reduced the use of D-dimer testing among patients 65 years and older. A single-crossover cluster randomized trial of computerized ...

Researchers from Kaiser Permanente in Denver have concluded that targeted age-specific computerized alerts can reduce the number of D-dimer testing needed in elderly patients, according to the study’s ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise diagnostic ...

The increased availability of D-Dimer testing—a blood test that checks for, or monitors, blood-clotting problems—may be a vital aid to the early diagnosis of venom-induced consumption coagulopathy ...

Des Plaines, IL — A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), ...

February 10, 2023 – Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of ...

NEW YORK, Nov. 18, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for D-dimer Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$2.7 ...